Clinical Trial Update: Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating dose-escalated subcutaneous ghrelin for cancer cachexia has completed. The study enrolled patients with advanced cancer and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Cancer

Drugs mentioned

• Ghrelin (ghrelin)

Snippet

Sponsor: Cantonal Hospital of St. Gallen | Conditions: Advanced Cancer, Cachexia | Phase 1, Phase 2 | Status: COMPLETED